Eric Sachetta bought $5,003 of SRTS
director at Sensus Healthcare, Inc.. 1,500 shares at an average of $3.34, traded May 12, 2026, filed May 12, 2026.
Score components
- +15RoleDirector
- 0Trade size$5k at market
- 0Relative to holdingsHoldings up 1.1%
- +18Price context9% above the 52-week low; 40% below the 52-week high
- 0ClusterNo other insider buying within 14 days
- +5Repeat buying2 buys in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0002097345-26-000008, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| May 12, 2026 | POpen-market purchase Common Stock | +1,500 | $3.34 | $5,003 | 143,613 | May 12, 2026 |
Related signals
Other insiders at Sensus Healthcare, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 50Moderate | Sensus Healthcare, Inc. | Eric Sachetta director | $226k 64,841 shares | +28% | |
| 42Moderate | Sensus Healthcare, Inc. | Eric Sachetta director | $67k 20,633 shares | +10% | |
| 44Moderate | Sensus Healthcare, Inc. | Eric Sachetta director | $113k 34,697 shares | +20% | |
| 42Moderate | Sensus Healthcare, Inc. | Eric Sachetta director | $98k 31,000 shares | +22% | |
| 48Moderate | Sensus Healthcare, Inc. | Joseph C Sardano CHIEF EXECUTIVE OFFICER | $60k 20,000 shares | +2% | |
| 23Weak | SRTSbuy Sensus Healthcare, Inc. | Eric Sachetta director | $7,620 2,000 shares | +1% | |
| 43Moderate | Sensus Healthcare, Inc. | Eric Sachetta director | $28k 7,000 shares | +5% | |
| 30Weak | Sensus Healthcare, Inc. | Eric Sachetta director | $11k 2,500 shares | +2% | |
| 50Moderate | Sensus Healthcare, Inc. | Joseph C Sardano CHIEF EXECUTIVE OFFICER | $101k 25,000 shares | +2% | |
| 35Weak | Sensus Healthcare, Inc. | Michael Sardano PRESIDENT AND GENERAL COUNSEL | $3,800 1,000 shares | +1% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.